NCT04832945 is a clinical trial of Ivermectin 6 Mg Oral Tablet in Covid19, sponsored by Grupo Rescue S.A.S República Dominicana.

Who is sponsoring NCT04832945?

NCT04832945 is sponsored by Grupo Rescue S.A.S República Dominicana.

What drugs are being tested in NCT04832945?

Interventions in NCT04832945: Ivermectin 6 Mg Oral Tablet.

Is NCT04832945 still recruiting?

NCT04832945 is currently completed. Last updated 13 April 2021.

Last reviewed 2021-04-13 · How we verify

NCT04832945

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study

Completed Last updated 13 April 2021

What this trial tests

trial testing Ivermectin 6 Mg Oral Tablet in Covid19 in 713 participants. Completed in 10 April 2021.

Timeline

29 June 2020

Primary endpoint
20 September 2020

10 April 2021

Quick facts

Lead sponsor	Grupo Rescue S.A.S República Dominicana
Status	Completed
Study type	OBSERVATIONAL
Enrollment	713
Start date	29 June 2020
Primary completion	20 September 2020
Estimated completion	10 April 2021
Sites	2 locations across Dominican Republic

Drugs / interventions tested

Ivermectin 6 Mg Oral Tablet — full drug profile →

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

Grupo Rescue S.A.S República Dominicana

Who can join

18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study, a multicenter retrospective cohort database study, carried out in two medical centers, Centro Medico Bournigal (CMBO) in Puerto Plata and Centro Medico Punta Cana (CMPC) in Punta Cana, Dominican Republic, sought to determine whether Ivermectin, at a weekly orally dose of 0.2 mg/kg, is an effective pre-exposure prophylactic method (PrEP) for the spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), in the healthcare workers. The study began on June 29, 2020 and ended on July 26, 2020 (4 weeks).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Potential Prophylactic Treatments for COVID-19.
Ben-Zuk N, Dechtman ID, Henn I, Weiss L, et al · · 2021 · cited 9× · PMID 34372498 · DOI 10.3390/v13071292
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study.
Morgenstern J, Redondo JN, Olavarria A, Rondon I, et al · · 2021 · cited 8× · PMID 34513523 · DOI 10.7759/cureus.17455
Retrospective cohort study of Ivermectin as a SARS-CoV-2 pre-exposure prophylaxis method in Healthcare Workers
Morgenstern J, Redondo JN, Olavarría Á, Rondon I, et al · · 2021 · cited 1× · DOI 10.1101/2021.04.10.21255248

Verify or expand the search:

Other trials of Ivermectin 6 Mg Oral Tablet

Trials testing the same drug.

NCT06251739 — Repurposing Ivermectin for PKDL Treatment · EARLY_PHASE1 · completed

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04832945 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Grupo Rescue S.A.S República Dominicana
Last refreshed: 13 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04832945.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing